Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 May 29;111(1):68–77. doi: 10.1038/bjc.2014.282

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014 Cancer Research UK

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

PMC Copyright notice

The structure and characterisation of FGF-Trap.(A) Schematic representation of the structure of FGF-Trap. (B and C) Sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS–PAGE) analyses of FGF-Trap under non-reducing (B) and reducing (C) conditions. Lane 1, protein marker; lane 2, 1 μg FGF-Trap; lane 3, 10 μg FGF-Trap. (D) Binding affinity of FGF-Trap for FGF-2 was determined by incubation of FGF-Trap with 10 pM FGF-2. (E) Pharmacokinetic analysis of FGF-Trap. FGF-Trap of 100 μg was intraperitoneally injected into BALB/c nude mice, and blood was drawn at the indicated time points. The serum level of FGF-Trap was measured by enzyme-linked immunosorbent assay. The colour reproduction of this figure is available on the British Journal of Cancer journal online.